Citigroup’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $927K | Sell |
|
|||||
|
2025
Q1 | $967K | Sell |
|
|||||
|
2024
Q4 | $1.31M | Buy |
|
|||||
|
2024
Q3 | $1.18M | Buy |
|
|||||
|
2024
Q2 | $440K | Sell |
|
|||||
|
2024
Q1 | $1.08M | Buy |
|
|||||
|
2023
Q4 | $85.5K | Sell |
|
|||||
|
2023
Q3 | $63.2K | Sell |
|
|||||
|
2023
Q2 | $187K | Buy |
|
|||||
|
2023
Q1 | $97.1K | Buy |
|
|||||
|
2022
Q4 | $20.9K | Sell |
|
|||||
|
2022
Q3 | $33K | Sell |
|
|||||
|
2022
Q2 | $826K | Buy |
|
|||||
|
2022
Q1 | $101K | Sell |
|
|||||
|
2021
Q4 | $231K | Sell |
|
|||||
|
2021
Q3 | $457K | Buy |
|
|||||
|
2021
Q2 | $298K | Buy |
|
|||||
|
2021
Q1 | $233K | Sell |
|
|||||
|
2020
Q4 | $445K | Sell |
|
|||||
|
2020
Q3 | $169K | Buy |
|
|||||
|
2020
Q2 | $91K | Sell |
|
|||||
|
2020
Q1 | $80K | Buy |
|
|||||
|
2019
Q4 | $45K | Sell |
|
|||||
|
2019
Q3 | $42K | Buy |
|
|||||
|
2019
Q2 | $43K | Sell |
|
|||||
|
2019
Q1 | $43K | Sell |
|
|||||
|
2018
Q4 | $78K | Buy |
|
|||||
|
2018
Q3 | $13K | Sell |
|
|||||
|
2018
Q2 | $94K | Buy |
|
|||||
|
2018
Q1 | $55K | Sell |
|
|||||
|
2017
Q4 | $57K | Buy |
|
|||||
|
2017
Q3 | $40K | Buy |
|
|||||
|
2017
Q2 | $39K | Sell |
|
|||||
|
2017
Q1 | $48K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $8K | Sell |
|
|||||
|
2016
Q1 | $102K | Buy |
|
|||||
|
2015
Q4 | $44K | Buy |
|
|||||
|
2015
Q3 | $0 | Sell |
|
|||||
|
2015
Q2 | $4K | Sell |
|
|||||
|
2015
Q1 | $13K | Sell |
|
|||||
|
2014
Q4 | $698K | Buy |
|
|||||
|
2014
Q3 | $3K | Buy |
|